Intestinal absorption of vitamin D 3  in epileptic patients and phenobarbital-treated rats.
D000328:Adult; D000368:Aged; D000818:Animals; D000927:Anticonvulsants / Q000009:adverse effects / Q000494:pharmacology* / Q000627:therapeutic use; D002762:Cholecalciferol / Q000097:blood / Q000378:metabolism* / Q000652:urine; D004827:Epilepsy / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D006801:Humans; D006900:Hydroxylation; D007408:Intestinal Absorption / Q000187:drug effects*; D008099:Liver / Q000032:analysis / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010018:Osteomalacia / Q000139:chemically induced; D010634:Phenobarbital / Q000494:pharmacology; D051381:Rats; D013057:Spectrum Analysis; D014316:Tritium
D000927:Anticonvulsants; D014316:Tritium; D002762:Cholecalciferol; D010634:Phenobarbital